These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 34311011)

  • 21. [Cardiopulmonary exercise testing (CPET)to evaluate the efficacy after intensive control of personalized precise exercise training for cardiovascular and cerebrovascular chronic diseases].
    Song Y; Sun XG; Xie YH; Tai WQ; Wang JN; Zhang Y; Zhang YF; Shi C; He LL; Hao L; Liu F; Feng J; Zhang ZY; Liu YL; Yu H
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2021 Jan; 37(1):79-88. PubMed ID: 34672467
    [No Abstract]   [Full Text] [Related]  

  • 22. CPAP Effect on Cardiopulmonary Exercise Testing Performance in Patients with Moderate-Severe OSA and Cardiometabolic Comorbidities.
    Zota IM; Stătescu C; Sascău RA; Roca M; Gavril RS; Vasilcu TF; Boișteanu D; Maștaleru A; Jitaru A; Leon Constantin MM; Mitu F
    Medicina (Kaunas); 2020 Feb; 56(2):. PubMed ID: 32075328
    [No Abstract]   [Full Text] [Related]  

  • 23. Prognostic value of aerobic capacity and exercise oxygen pulse in postaortic dissection patients.
    Delsart P; Delahaye C; Devos P; Domanski O; Azzaoui R; Sobocinski J; Juthier F; Vincentelli A; Rousse N; Mugnier A; Soquet J; Loobuyck V; Koussa M; Modine T; Jegou B; Bical A; Hysi I; Fabre O; Pontana F; Matran R; Mounier-Vehier C; Montaigne D
    Clin Cardiol; 2021 Feb; 44(2):252-260. PubMed ID: 33381882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced exercise capacity, chronotropic incompetence, and early systemic inflammation in cardiopulmonary phenotype Long COVID.
    Durstenfeld MS; Peluso MJ; Kaveti P; Hill C; Li D; Sander E; Swaminathan S; Arechiga VM; Lu S; Goldberg SA; Hoh R; Chenna A; Yee BC; Winslow JW; Petropoulos CJ; Kelly JD; Glidden DV; Henrich TJ; Martin JN; Lee YJ; Aras MA; Long CS; Grandis DJ; Deeks SG; Hsue PY
    medRxiv; 2023 Mar; ():. PubMed ID: 35677073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiopulmonary Exercise Testing in Post-COVID-19 Patients: Where Does Exercise Intolerance Come From?
    Milani M; Milani JGPO; Cipriano GFB; Cahalin LP; Stein R; Cipriano G
    Arq Bras Cardiol; 2023 Feb; 120(2):e20220150. PubMed ID: 36888777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exercise testing in survivors of intensive care--is there a role for cardiopulmonary exercise testing?
    Benington S; McWilliams D; Eddleston J; Atkinson D
    J Crit Care; 2012 Feb; 27(1):89-94. PubMed ID: 21958985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of Duke Activity Status Index with cardiopulmonary exercise testing in cancer patients.
    Li MH; Bolshinsky V; Ismail H; Ho KM; Heriot A; Riedel B
    J Anesth; 2018 Aug; 32(4):576-584. PubMed ID: 29845328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of Cardiopulmonary Exercise Testing to Evaluate Long COVID-19 Symptoms in Adults: A Systematic Review and Meta-analysis.
    Durstenfeld MS; Sun K; Tahir P; Peluso MJ; Deeks SG; Aras MA; Grandis DJ; Long CS; Beatty A; Hsue PY
    JAMA Netw Open; 2022 Oct; 5(10):e2236057. PubMed ID: 36223120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Body composition and maximal exercise capacity after heart transplantation.
    Regamey J; Monney P; Yerly P; Favre L; Kirsch M; Tozzi P; Lamy O; Hullin R
    ESC Heart Fail; 2022 Feb; 9(1):122-132. PubMed ID: 34854252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiopulmonary exercise testing variables as predictors of long-term outcome in thoracic sarcoidosis.
    Lopes AJ; Menezes SL; Dias CM; Oliveira JF; Mainenti MR; Guimarães FS
    Braz J Med Biol Res; 2012 Mar; 45(3):256-63. PubMed ID: 22331135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiopulmonary exercise testing excludes significant disease in patients recovering from COVID-19.
    Holdsworth DA; Barker-Davies RM; Chamley RR; O'Sullivan O; Ladlow P; May S; Houston AD; Mulae J; Xie C; Cranley M; Sellon E; Naylor J; Halle M; Parati G; Davos C; Rider OJ; Bennett AB; Nicol ED
    BMJ Mil Health; 2024 Jul; 170(4):308-314. PubMed ID: 36442889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiopulmonary exercise testing during follow-up after acute pulmonary embolism.
    Farmakis IT; Valerio L; Barco S; Alsheimer E; Ewert R; Giannakoulas G; Hobohm L; Keller K; Mavromanoli AC; Rosenkranz S; Morris TA; Konstantinides SV; Held M; Dumitrescu D
    Eur Respir J; 2023 Jun; 61(6):. PubMed ID: 36958742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peak oxygen consumption by smartwatches compared with cardiopulmonary exercise test in complex congenital heart disease.
    Tran T; Steiner JM; Venkateswaran A; Buber J
    Heart; 2024 Feb; 110(5):353-358. PubMed ID: 37827554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiopulmonary exercise testing in patients with chronic obstructive pulmonary disease.
    Ong KC; Ong YY
    Ann Acad Med Singap; 2000 Sep; 29(5):648-52. PubMed ID: 11126703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxygen uptake kinetics and chronotropic responses to exercise are impaired in survivors of severe COVID-19.
    Longobardi I; Prado DMLD; Goessler KF; Meletti MM; de Oliveira Júnior GN; de Andrade DCO; Gualano B; Roschel H
    Am J Physiol Heart Circ Physiol; 2022 Sep; 323(3):H569-H576. PubMed ID: 35984763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiopulmonary Exercise Testing to Assess Persistent Symptoms at 6 Months in People With COVID-19 Who Survived Hospitalization: A Pilot Study.
    Debeaumont D; Boujibar F; Ferrand-Devouge E; Artaud-Macari E; Tamion F; Gravier FE; Smondack P; Cuvelier A; Muir JF; Alexandre K; Bonnevie T
    Phys Ther; 2021 Jun; 101(6):. PubMed ID: 33735374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of Cardiopulmonary Stress Testing for Patients With Unexplained Dyspnea Post-Coronavirus Disease.
    Mancini DM; Brunjes DL; Lala A; Trivieri MG; Contreras JP; Natelson BH
    JACC Heart Fail; 2021 Dec; 9(12):927-937. PubMed ID: 34857177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiopulmonary exercise testing in the evaluation of functional capacity after treatment of lymphomas in adults.
    Elbl L; Vasova I; Tomaskova I; Jedlicka F; Kral Z; Navratil M; Smardova L; Wagnerova B; Vorlicek J
    Leuk Lymphoma; 2006 May; 47(5):843-51. PubMed ID: 16753868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiopulmonary exercise capacity and limitations 3 months after COVID-19 hospitalisation.
    Skjørten I; Ankerstjerne OAW; Trebinjac D; Brønstad E; Rasch-Halvorsen Ø; Einvik G; Lerum TV; Stavem K; Edvardsen A; Ingul CB
    Eur Respir J; 2021 Aug; 58(2):. PubMed ID: 34210791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in cardiopulmonary exercise capacity and limitations 3-12 months after COVID-19.
    Ingul CB; Edvardsen A; Follestad T; Trebinjac D; Ankerstjerne OAW; Brønstad E; Rasch-Halvorsen Ø; Aarli B; Dalen H; Nes BM; Lerum TV; Einvik G; Stavem K; Skjørten I
    Eur Respir J; 2023 Feb; 61(2):. PubMed ID: 36137587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.